OTC · Medical - Diagnostics & Research

AccuStem Sciences Limited (ACMSY) Stock

$0.13 -7.14% OTC: ACMSY Healthcare

AccuStem Sciences Limited, founded in 2020 and headquartered in London, United Kingdom, focuses on providing diagnostic assays that utilize genomic signatures. These tests are developed to forecast the probability of both short-term and long-term relapse of ER+/HER2 breast cancer in individuals with an early-stage diagnosis.

Valuation

MetricValue
Price$0.13
Market Cap$0
P/E Ratio-1.08
P/B Ratio-0.54
P/S Ratio0.00
EPS (TTM)$-0.12
52-Week High$0.13
52-Week Low$0.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE58533.33%
ROA-113.36%
ROCE-113.73%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio9.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-4.0M$-2.0M$-2.0M$-1.8B
Net Profit$-1.0M$-4.0M$-2.0M$-2.0M$-1.8B
EPS$-0.07$-0.34$-0.18$-0.13$-0.12
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M—$0$1.5B
Total Liabilities$1.0M$1.0M—$3.0M$5.0M
Cash$0$1.0M—$0$14.0M
Borrowings$0$0$0$0$0

Latest News

FOMC Preview: Fed likely to hold rates despite oil spike, Citi sees dovish outcome Investing.com · Jul 26, 2026 I've stayed in hundreds of Airbnbs across nearly 100 countries. These are the 9 amenities that saved me thousands Moneywise · Jul 26, 2026 Which Is the Better Vanguard Short-Term Bond ETF, Corporate Bond-Focused VCSH or BSV's Treasury Emphasis? Motley Fool · Jul 26, 2026 Is It Really Safe to Invest in the Vanguard S&P 500 ETF Right Now? Here's What History Says. Motley Fool · Jul 26, 2026 Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio? Motley Fool · Jul 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow—$-2.0M—$-1.0M$-850.0M
Investing Cash Flow—$0—$0$0
Financing Cash Flow—$3.0M—$1.0M$859.0M
Net Cash Flow—$1.0M—$0$9.0M
Free Cash Flow$0$-2.0M$0$-1.0M$-850.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA0.01
FCF Yield—
Quick Ratio0.01
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About AccuStem Sciences Limited

AccuStem Sciences Limited, founded in 2020 and headquartered in London, United Kingdom, focuses on providing diagnostic assays that utilize genomic signatures. These tests are developed to forecast the probability of both short-term and long-term relapse of ER+/HER2 breast cancer in individuals with an early-stage diagnosis.

the stock is valued at a negative price-to-earnings (P/E) ratio of -1.08, reflecting a net loss over the last twelve months, a negative price-to-book of -0.54, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.12 and $0.13, and currently trades at or near its 52-week high.

On profitability, AccuStem Sciences Limited generates a return on equity (ROE) of 58533.33%, above the typical market range of roughly 12-15%, return on capital employed of -113.73%.

Official website: www.accustem.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.